Weave Bio

Weave Bio is an artificial intelligence company in San Francisco, United States, founded in 2023. It has raised $30.0M across 2 rounds, most recently a $20.0M Series A in October 2025.

The AI platform built for drug development

Employees
11–50
Founded
2023
Business Model
B2B
Website
weave.bio
Total Funding
$30.0M
Last Round
$20.0M Series AOct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Weave Bio is an AI-native regulatory automation platform built for drug development. Founded in 2023 and headquartered in San Francisco, Weave supports the entire regulatory content lifecycle — from authoring and data extraction to submission publishing and response management. The platform helps pharmaceutical companies, biotech firms, and CROs automate IND filings, HAQ management, and global regulatory submissions. Weave's AI infuses intelligence into every step of the workflow, including data verification, document drafting, and review, enabling regulatory teams to navigate evolving frameworks from agencies such as the FDA faster and with greater confidence. Co-founded by Brandon Rice (CEO) and Ari Caroline (CSO), the company's mission is to equip human regulatory experts with AI tools that reduce time-to-submission without sacrificing quality, ultimately helping life-saving therapies reach patients sooner. Partners include Parexel, and the platform is backed by leading life science investors.

Summary

It lists 11–50 employees. It has raised $30.0M in total across 2 rounds, most recently a $20.0M Series A round in Oct 2025. Investors include Innovation Endeavors, US Venture Partners and Magnetic.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AOct 2025
$20.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

EdifecsAcquired

Edifecs delivers healthcare technology that unifies data for nearly 300 million people, powering ...

Bellevue, United States1001–5000Artificial Intelligence, Healthcare
Growth EquityTotal funding$1.4BJul 2020
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026
ByteDance

ByteDance is a Chinese technology company that utilizes AI to distribute content based on users' ...

Beijing, China10001+Social Media, Artificial Intelligence
Growth EquityTotal funding$6.1BOct 2018
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Genesys

Genesys empowers more than 8,000 organizations worldwide with Genesys Cloud, an agentic AI experi...

Daly City, United States5001–10000Artificial Intelligence, SaaS
Growth EquityTotal funding$4.5BJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Weave Bio on Indexed.vc
<a href="https://indexed.vc/companies/weave-bio"><img src="https://indexed.vc/api/badge/company/weave-bio" alt="Weave Bio on Indexed.vc" width="260" height="76" /></a>